# YELLOW FEVER VACCINE

Canonical: https://abierto.us/opportunities/spe2dp24q0084

- Solicitation number: SPE2DP24Q0084
- Notice type: Sources sought
- Status: Closed. Deadline was March 18, 2024 at 5:00 AM EDT
- Department: Department of Defense
- Agency: Defense Logistics Agency
- Contracting office: DLA Troop Support (SPE2DP)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- First posted: March 14, 2024
- Last posted: March 14, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/b33fd3f20f3d459b80f9f7f632cbaed0/view

## Description

The Defense Logistics Agency- Troop Support is seeking sources capable of providing YELLOW FEVER VACCINE, USP, One Vial (Sufficient for 5 Doses). CONTAINS 3ML.

**UNIT OF ISSUE:** "EACH" (1 VIAL). REQ REFRIG. BTWN 2-8 DEG. C; SUBJECT TO DAMAGE BY FREEZING. Shelf life is 12 months. At least 10 months of shelf life shall remain at the time of delivery to the first government activity. DLA Troop Support has a requirement for Yellow Fever Vaccine of 47 Vials. The vaccine shall be delivered to the Defense Distribution Depot Norfolk, VA, and the desirable delivery time is end of March 2024. This is a request for information (RFI) and does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to the RFI. All submitted information shall remain with the U.S. Government and will not be returned.

Currently Marketed YELLOW FEVER VACCINE

If your firm currently markets YELLOW FEVER VACCINE, please provide information with respects to the following:

1.Place of Manufacture 2.FDA registration information 3.Product Name and description including description of any special features 4.Current unit sale price 5.Delivery days for this item and earliest product available time

New Products Under Development

For products under development, describe the current stage of development and whether the product has undergone independent laboratory testing or FDA testing/trials etc. Firms and organizations that currently develop or manufacture product described in this RFI or that have technologies, pharmaceuticals, or manufacturing capabilities under development are invited to submit information to DLA Troop Support.

Data obtained from this Request For Information (RFI) will be used by DLA Troop Support in making recommendations and decisions on the development of an appropriate planning and procurement strategy for Yellow Fever Vaccine.

All information submitted will be kept confidential as allowed by relevant Federal law and will be eligible for additional special protections under the conditions of the Protected Critical Infrastructure Information (PCII) Program outlined in the Critical Infrastructure Information Act of 2002. Your response to this RFI may be submitted electronically in pdf format and emailed to the Contracting Officer shairy.cartagena@dla.mil.

## Publications

- March 14, 2024: Sources sought, due March 18, 2024 at 5:00 AM EDT. Notice b33fd3f20f3d459b80f9f7f632cbaed0. https://sam.gov/workspace/contract/opp/b33fd3f20f3d459b80f9f7f632cbaed0/view

## Points of contact

- Shairy M. Cartagena215-737-0730, Shairy.Cartagena@dla.mil, 215.737.0730

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/spe2dp24q0084.